ATE342507T1 - PHARMAKOPHORE REKOMBINATION ZUR IDENTIFIZIERUNG VON ßLEADß-VERBINDUNGEN VON KLEINMOLEKÜL- MEDIKAMENTEN - Google Patents

PHARMAKOPHORE REKOMBINATION ZUR IDENTIFIZIERUNG VON ßLEADß-VERBINDUNGEN VON KLEINMOLEKÜL- MEDIKAMENTEN

Info

Publication number
ATE342507T1
ATE342507T1 AT99914218T AT99914218T ATE342507T1 AT E342507 T1 ATE342507 T1 AT E342507T1 AT 99914218 T AT99914218 T AT 99914218T AT 99914218 T AT99914218 T AT 99914218T AT E342507 T1 ATE342507 T1 AT E342507T1
Authority
AT
Austria
Prior art keywords
ßleadß
identifying
compounds
small molecule
molecule drugs
Prior art date
Application number
AT99914218T
Other languages
English (en)
Inventor
Jonathan A Ellman
Ingrid Choong
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE342507T1 publication Critical patent/ATE342507T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT99914218T 1998-03-27 1999-03-26 PHARMAKOPHORE REKOMBINATION ZUR IDENTIFIZIERUNG VON ßLEADß-VERBINDUNGEN VON KLEINMOLEKÜL- MEDIKAMENTEN ATE342507T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/049,754 US6344330B1 (en) 1998-03-27 1998-03-27 Pharmacophore recombination for the identification of small molecule drug lead compounds

Publications (1)

Publication Number Publication Date
ATE342507T1 true ATE342507T1 (de) 2006-11-15

Family

ID=21961533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99914218T ATE342507T1 (de) 1998-03-27 1999-03-26 PHARMAKOPHORE REKOMBINATION ZUR IDENTIFIZIERUNG VON ßLEADß-VERBINDUNGEN VON KLEINMOLEKÜL- MEDIKAMENTEN

Country Status (9)

Country Link
US (5) US6344330B1 (de)
EP (1) EP1066522B1 (de)
JP (1) JP2002507748A (de)
AT (1) ATE342507T1 (de)
AU (1) AU759327B2 (de)
CA (1) CA2326341C (de)
DE (1) DE69933549T2 (de)
IL (1) IL138717A0 (de)
WO (1) WO1999049314A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6998233B2 (en) 1998-06-26 2006-02-14 Sunesis Pharmaceuticals, Inc. Methods for ligand discovery
US6919178B2 (en) 2000-11-21 2005-07-19 Sunesis Pharmaceuticals, Inc. Extended tethering approach for rapid identification of ligands
US20050287596A9 (en) * 1998-06-26 2005-12-29 Braisted Andrew C Novel ligands and libraries of ligands
US20030194745A1 (en) * 1998-06-26 2003-10-16 Mcdowell Robert S. Cysteine mutants and methods for detecting ligand binding to biological molecules
US6824987B1 (en) * 1999-05-11 2004-11-30 President And Fellows Of Harvard College Small molecule printing
EP1441228B1 (de) * 2000-11-21 2006-06-28 Sunesis Pharmaceuticals, Inc. Erweiterter "thethering" Ansatz zum schnellen Auffinden von Liganden
US20020172967A1 (en) * 2001-02-13 2002-11-21 Gadek Thomas R. Identification of non-covalent complexes by mass spectrometry
US20040017884A1 (en) * 2002-07-25 2004-01-29 Havrilla George J. Flow method and apparatus for screening chemicals using micro x-ray fluorescence
US9157875B2 (en) * 2001-05-16 2015-10-13 Benjamin P. Warner Drug development and manufacturing
US6858148B2 (en) 2003-07-16 2005-02-22 The Regents Of The University Of California Method and apparatus for detecting chemical binding
NZ530811A (en) * 2001-08-07 2005-07-29 Sunesis Pharmaceuticals Inc Disulfide and thiosulfonate ligands and libraries comprising these ligands
AU2002254725A1 (en) * 2001-11-21 2003-06-10 Sunesis Pharmaceuticals, Inc. Methods for ligand discovery
CA2493461C (en) 2002-07-24 2013-01-08 Dror Ofer Drug discovery method
US7519145B2 (en) * 2002-07-25 2009-04-14 Los Alamos National Security, Llc Flow method and apparatus for screening chemicals using micro x-ray fluorescence
US7491312B2 (en) * 2002-10-30 2009-02-17 Edison Pharmaceuticals, Inc. Identifying therapeutic compounds based on their physical-chemical properties
ATE354096T1 (de) 2002-12-23 2007-03-15 Astex Therapeutics Ltd Synthese und screening von liganden mit hilfe von röntgenkristallographie
US7736909B2 (en) * 2003-01-09 2010-06-15 Board Of Regents, The University Of Texas System Methods and compositions comprising capture agents
US20040265909A1 (en) * 2003-04-11 2004-12-30 Jeff Blaney Compound libraries and methods for drug discovery
US20070003954A1 (en) * 2005-05-12 2007-01-04 The Board Of Regents Of The University Of Texas System Protein and antibody profiling using small molecule microarrays
DK1934388T3 (da) * 2005-10-04 2013-02-25 Alchemia Ltd Fremgangsmåde til lægemiddeludvikling
WO2008013569A2 (en) * 2006-01-03 2008-01-31 The President And Fellows Of Harvard College Small molecule printing
EP2084519B1 (de) 2006-10-10 2012-08-01 Los Alamos National Security, LLC Röntgenfluoreszenz-analyseverfahren
DE102007023102A1 (de) * 2006-12-19 2008-06-26 Bayer Cropscience Ag Bisoxime als Fungizide
US20090087919A1 (en) 2007-09-28 2009-04-02 Caldera Pharmaceuticals, Inc. Method and Apparatus for Measuring Protein Post-Translational Modification
US10107798B2 (en) 2008-03-25 2018-10-23 Sunesis Pharmaceuticals, Inc. Methods of chemotype evolution
RU2563822C2 (ru) * 2009-05-29 2015-09-20 Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем Пептоидные лиганды для выделения и обработки аутоиммунных т-клеток
US9551721B2 (en) * 2009-06-02 2017-01-24 The Board Of Regents Of The University Of Texas System Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
WO2011047257A1 (en) * 2009-10-16 2011-04-21 The Board Of Regents Of The University Of Texas System Compositions and methods for producing cyclic peptoid libraries
BR112012033490A2 (pt) 2010-07-02 2015-09-15 Syngenta Participations Ag derivados de éter dioxima microbicida
CA2804355A1 (en) 2010-07-29 2012-02-02 Syngenta Participations Ag Novel microbiocidal dioxime ether derivatives
WO2012129423A2 (en) 2011-03-24 2012-09-27 Opko Pharmaceuticals, Llc Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics
WO2013024040A2 (en) 2011-08-12 2013-02-21 B.S.R.C. Alexander Fleming Tnf superfamily trimerization inhibitors
WO2013092460A1 (en) 2011-12-20 2013-06-27 Syngenta Participations Ag Cyclic bisoxime microbicides
CN102731450A (zh) * 2012-07-04 2012-10-17 中山大学 一种苯并呋喃或吲哚的制备方法
WO2015023724A1 (en) 2013-08-13 2015-02-19 The Scripps Research Institute Cysteine-reactive ligand discovery in proteomes
CN104897826B (zh) * 2015-06-16 2016-06-22 广西师范大学 一种用于细胞原位检测小分子化合物与靶蛋白相互作用的方法
CA2999800A1 (en) 2015-08-11 2017-02-16 Stephen Mark Robbins Dpep-1 binding compositions and methods of use
EP3365686A4 (de) 2015-10-22 2019-03-27 The Scripps Research Institute Reaktive cysteinsonden und verwendungen davon
US10458995B2 (en) 2016-03-25 2019-10-29 Muralidhar Reddy Moola Combinatorial synthesis and biomarker development
EP3570829A4 (de) 2017-01-18 2021-03-10 The Scripps Research Institute Fotoreaktive liganden und verwendungen davon

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727022A (en) 1984-03-14 1988-02-23 Syntex (U.S.A.) Inc. Methods for modulating ligand-receptor interactions and their application
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
US5196351A (en) 1987-09-30 1993-03-23 Beckman Instruments, Inc. Bidentate conjugate and method of use thereof
FR2651229B1 (fr) * 1989-08-24 1991-12-13 Inst Nat Sante Rech Med Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique.
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
DE69233367T2 (de) 1991-04-10 2005-05-25 The Scripps Research Institute, La Jolla Bibliotheken heterodimerer rezeptoren mittels phagemiden
AU664184B2 (en) * 1991-07-15 1995-11-09 La Jolla Pharmaceutical Company Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
EP0635023B1 (de) 1992-03-05 2002-02-06 Isis Pharmaceuticals, Inc. Kovalent vernetzte oligonukleotide
US5543507A (en) 1992-03-05 1996-08-06 Isis Pharmaceuticals, Inc. Covalently cross-linked oligonucleotides
US5362859A (en) 1992-07-27 1994-11-08 Sepracor, Inc. High-capacity affinity supports and methods for the preparation and use of same
US5512435A (en) 1993-02-05 1996-04-30 Renschler; Markus F. Receptor-binding antiproliferative peptides
WO1996033416A1 (en) * 1995-04-20 1996-10-24 Lxr Biotechnology Inc. Methods of screening for therapeutic agents using novel apoptosis-modulating proteins
DE19521019A1 (de) * 1995-06-13 1996-12-19 Boehringer Mannheim Gmbh Verfahren und Mittel zur gleichzeitigen kolorimetrischen und elektrochemischen Messung eines Analyten
US5698401A (en) 1995-11-14 1997-12-16 Abbott Laboratories Use of nuclear magnetic resonance to identify ligands to target biomolecules
IL123572A (en) 1995-11-14 2004-06-01 Abbott Lab Use of two-dimensional <15>n/<1>h nmr correlation spectroscopy in a process for designing high-affinity ligands to target molecules
WO1998011436A1 (en) 1996-09-13 1998-03-19 Whitehead Institute For Biomedical Research Non-specific affinity enhancement to identify combinatorial library members
US6552060B1 (en) * 1997-08-11 2003-04-22 Prolx Pharmaceuticals, Inc. Asymmetric disulfides and methods of using same
US6043024A (en) 1997-04-18 2000-03-28 Abbott Laboratories Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6335155B1 (en) * 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
US7135288B2 (en) * 2002-09-27 2006-11-14 Ut-Battelle, Llc Combinatorial synthesis of ceramic materials

Also Published As

Publication number Publication date
AU759327B2 (en) 2003-04-10
DE69933549D1 (de) 2006-11-23
EP1066522A1 (de) 2001-01-10
EP1066522B1 (de) 2006-10-11
DE69933549T2 (de) 2007-06-21
AU3211399A (en) 1999-10-18
EP1066522A4 (de) 2005-02-02
CA2326341C (en) 2009-02-17
US6344334B1 (en) 2002-02-05
IL138717A0 (en) 2001-10-31
WO1999049314A1 (en) 1999-09-30
JP2002507748A (ja) 2002-03-12
US6344330B1 (en) 2002-02-05
US7001727B2 (en) 2006-02-21
US20020115107A1 (en) 2002-08-22
US20040063157A1 (en) 2004-04-01
CA2326341A1 (en) 1999-09-30
US20040132100A1 (en) 2004-07-08
WO1999049314A9 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
ATE342507T1 (de) PHARMAKOPHORE REKOMBINATION ZUR IDENTIFIZIERUNG VON ßLEADß-VERBINDUNGEN VON KLEINMOLEKÜL- MEDIKAMENTEN
BR9916146A (pt) Produto de revestimento constituìdo de três componentes, processo para sua produção, bem como utilização do mesmo
MX218513B (es) Composiciones para revestimiento, curables, con un contenido de mezclas de compuestos carbamato funcionales
EA200401107A1 (ru) Закодированные самособирающиеся химические библиотеки
BR9707016A (pt) Métodos e composições para analisar moléculas de ácido nuclêico utilizando técnicas dimensionamento.
DK0914331T3 (da) Neuroaktive peptider
ATE473292T1 (de) Sicherheitssystem
ID17810A (id) Turunan-turunan 2,4-tiazolidindion tersubstitusi baru, proses untuk pembuatannya dan komposisi farmasi yang mengandungnya
PT868427E (pt) Metodos para identificar compostos que se ligam a um alvo
BR9802354B1 (pt) método para impedir inspeção não autorizada de código fonte de um programa de computador.
EA200101017A1 (ru) Ингибиторы связывания lfa-1 с icam и их использование
DE69611677D1 (de) Pestizide schwefelverbindungen.
MX240611B (es) Composiciones curables de recbrimiento, que contienen mezclas de compuestos funcionales de carbamato
BR0007638A (pt) Processo para determinação pós-genÈmica de estruturas atÈmicas macromoleculares
ATE213944T1 (de) Verwendung von immunomodulatoren
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
ATE331814T1 (de) Sicherheitssystem
PT1051066E (pt) Etiqueta de enfiar no solo para plantas
ATE257255T1 (de) Verfahren zur absicherung von einsprungsadressen
BR9908586A (pt) Processo e dispositivo para processamento de dados depositados especificamente para o usuário em diversas memórias de dados de uma instalação técnica
WO2003012721A3 (en) Prediction models for molecular activity and protein binding
DE69836039D1 (de) Verdampfungsquelle für organisches Material
BR9802868B1 (pt) processo para o controle de populações de térmites subterráneas.
ATE323105T1 (de) Von lipocortin-1 abgeleitete entzündungshemmende wirkstoffe
DE69519282D1 (de) Markierungsanordnung für von Flagkörper zerstörte Ziele

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties